MGA and lung adenocarcinoma: To investigate whether MGA loss leads to similar functional consequences in vitro, we used either shRNA- or CRISPR-based approaches to delete or knock down MGA in A549 and NCI-H23 lung adenocarcinoma lines (Figure 7—figure supplement 1E,G).